Tag: CoQ10

Foods

• • beef
  • canola oil
  • lake trout
  • mackerel
  • olives and olive oil
  • peanuts
  • pork
  • sesame seeds and sesame oil
  • soybean oil

Studies

• The role of coenzyme Q10 as a preventive and therapeutic agent for the treatment of cancers Cite
  Ghasempour Dabaghi G, Rabiee Rad M, Mohammad-Zamani M, Karimi Shervedani A, Bahrami-Samani F, Heshmat-Ghahdarijani K. The role of coenzyme Q10 as a preventive and therapeutic agent for the treatment of cancers. Current Problems in Cancer. Elsevier BV; 2024; 48:101063 10.1016/j.currproblcancer.2024.101063
• Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients Cite
  Nilsson L, Khazaei S, Tryggvadottir H, Björner S, Bressan A, Jirström K, et al. Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients. Clinical Breast Cancer. Elsevier BV; 2023; 10.1016/j.clbc.2023.12.002
• The Biochemistry and Effectiveness of Antioxidants in Food, Fruits, and Marine Algae Cite
  Pruteanu LL, Bailey DS, Grădinaru AC, Jäntschi L. The Biochemistry and Effectiveness of Antioxidants in Food, Fruits, and Marine Algae. Antioxidants. MDPI AG; 2023; 12:860 10.3390/antiox12040860
• Coenzyme Q0 defeats NLRP3-mediated inflammation, EMT/metastasis, and Warburg effects by inhibiting HIF-1α expression in human triple-negative breast cancer cells Cite
  Yang H, Lin P, Vadivalagan C, Lin Y, Lin K, Hseu Y. Coenzyme Q0 defeats NLRP3-mediated inflammation, EMT/metastasis, and Warburg effects by inhibiting HIF-1α expression in human triple-negative breast cancer cells. Archives of Toxicology. Springer Science and Business Media LLC; 2023; 10.1007/s00204-023-03456-w
• Determination of enzyme Q10 levels in Pakistani female patients with breast cancer Cite
  Chanihoon GQ, Unar A, Memon AA, Afridi HI, Chandio A, Jaffar TH. Determination of enzyme Q10 levels in Pakistani female patients with breast cancer. Chinese Journal of Analytical Chemistry. Elsevier BV; 2022;:100061 10.1016/j.cjac.2022.100061
• Coenzyme Q10 protects against doxorubicin-induced cardiomyopathy via antioxidant and anti-apoptotic pathway Cite
  Shabaan DA, Mostafa N, El-Desoky MM, Arafat EA. Coenzyme Q10 protects against doxorubicin-induced cardiomyopathy via antioxidant and anti-apoptotic pathway. Tissue Barriers. Informa UK Limited; 2021; 10.1080/21688370.2021.2019504
• Synergistic Antiproliferative and Anticancer Activity of Carotenoid Lutein or Coenzyme Q10 in Combination with Doxorubicin on the MCF7 Cell Line Cite
  Shokrzadeh M, Mortazavi P, Moghadami A, Khayambashi B, Motafeghi F. Synergistic Antiproliferative and Anticancer Activity of Carotenoid Lutein or Coenzyme Q10 in Combination with Doxorubicin on the MCF7 Cell Line. Applied In Vitro Toxicology. Mary Ann Liebert Inc; 2021; 10.1089/aivt.2021.0008
• Revisiting the Anticancer Drug–Food Interactions Cite
  Gacche RN. Revisiting the Anticancer Drug–Food Interactions. Dietary Research and Cancer. Springer Singapore; 2021;:113-120 10.1007/978-981-16-6050-4_11
• Coenzyme Q10 in association with metabolism-related AMPK/PFKFB3 and angiogenic VEGF/VEGFR2 genes in breast cancer patients Cite
  Abdi S, Montazeri V, Garjani A, Shayanfar A, Pirouzpanah S. Coenzyme Q10 in association with metabolism-related AMPK/PFKFB3 and angiogenic VEGF/VEGFR2 genes in breast cancer patients. Molecular Biology Reports. Springer Science and Business Media LLC; 2020; 47:2459-2473 10.1007/s11033-020-05310-z
• Assessment of Serum CoQ10 Levels and other Antioxidant Markers in Breast Cancer Cite
  El-Attar E, Kamel A, Karmouty A, Wehida N, Nassra R, El Nemr M, et al. Assessment of Serum CoQ10 Levels and other Antioxidant Markers in Breast Cancer. Asian Pacific Journal of Cancer Prevention. EpiSmart Science Vector Ltd; 2020; 21:465-471 10.31557/apjcp.2020.21.2.465
• Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221) Cite
  Ambrosone CB, Zirpoli GR, Hutson AD, McCann WE, McCann SE, Barlow WE, et al. Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2019; 38:804-814 10.1200/jco.19.01203
• Coenzyme Q10 Cardioprotective Effects Against Doxorubicin-Induced Cardiotoxicity in Wistar Rat Cite
  Botelho AFM, Lempek MR, Branco SEMT, Nogueira MM, de Almeida ME, Costa AG, et al. Coenzyme Q10 Cardioprotective Effects Against Doxorubicin-Induced Cardiotoxicity in Wistar Rat. Cardiovascular Toxicology. Springer Science and Business Media LLC; 2019; 20:222-234 10.1007/s12012-019-09547-4
• Coenzyme Q0 Enhances Ultraviolet B–Induced Apoptosis in Human Estrogen Receptor–Positive Breast (MCF-7) Cancer Cells Cite
  Wang H, Yang H, Thiyagarajan V, Huang T, Huang P, Chen S, et al. Coenzyme Q0 Enhances Ultraviolet B–Induced Apoptosis in Human Estrogen Receptor–Positive Breast (MCF-7) Cancer Cells. Integrative Cancer Therapies. SAGE Publications; 2016; 16:385-396 10.1177/1534735416673907
• Protective effect of Co-enzyme Q10 On doxorubicin-induced cardiomyopathy of rat hearts Cite
  Chen P, Hou C, Shibu MA, Day CH, Pai P, Liu Z, et al. Protective effect of Co-enzyme Q10 On doxorubicin-induced cardiomyopathy of rat hearts. Environmental Toxicology. Wiley; 2016; 32:679-689 10.1002/tox.22270
• Coenzyme Q 0 regulates NFκB/AP-1 activation and enhances Nrf2 stabilization in attenuation of LPS-induced inflammation and redox imbalance: Evidence from in vitro and in vivo studies Cite
  Yang H, Lin M, Korivi M, Wu J, Liao C, Chang C, et al. Coenzyme Q 0 regulates NFκB/AP-1 activation and enhances Nrf2 stabilization in attenuation of LPS-induced inflammation and redox imbalance: Evidence from in vitro and in vivo studies. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. Elsevier BV; 2016; 1859:246-261 10.1016/j.bbagrm.2015.11.001
• Anti-angiogenic properties of coenzyme Q0 through downregulation of MMP-9/NF-κB and upregulation of HO-1 signaling in TNF-α-activated human endothelial cells Cite
  Yang H, Korivi M, Lin M, Chen S, Chou C, Hseu Y. Anti-angiogenic properties of coenzyme Q0 through downregulation of MMP-9/NF-κB and upregulation of HO-1 signaling in TNF-α-activated human endothelial cells. Biochemical Pharmacology. Elsevier BV; 2015; 98:144-156 10.1016/j.bcp.2015.09.003
• A Randomized, Double-Blind, Placebo-Controlled Study of Oral Coenzyme Q10 to Relieve Self-Reported Treatment-Related Fatigue in Newly Diagnosed Patients with Breast Cancer Cite
  Lesser GJ, Case D, Stark N, Williford S, Giguere J, Garino LA, et al. A Randomized, Double-Blind, Placebo-Controlled Study of Oral Coenzyme Q10 to Relieve Self-Reported Treatment-Related Fatigue in Newly Diagnosed Patients with Breast Cancer. The Journal of Supportive Oncology. Elsevier BV; 2012; 10.1016/j.suponc.2012.03.003
• Dangerous Combinations: Ingestible CAM Supplement Use During Chemotherapy in Patients with Ovarian Cancer Cite
  Andersen MR, Sweet E, Lowe KA, Standish LJ, Drescher CW, Goff BA. Dangerous Combinations: Ingestible CAM Supplement Use During Chemotherapy in Patients with Ovarian Cancer. The Journal of Alternative and Complementary Medicine. Mary Ann Liebert Inc; 2013; 19:714-720 10.1089/acm.2012.0295
• Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort Cite
  Greenlee H, Kwan ML, Kushi LH, Song J, Castillo A, Weltzien E, et al. Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. Cancer. Wiley; 2011; 118:2048-2058 10.1002/cncr.26526